Phosphatidylinositol 3 kinase inhibitor-related pneumonitis: a systematic review and meta-analysis

CONCLUSION: PI3K inhibitors significantly increased the risk of pneumonitis compared with controls, and most cases are severe or even life-threatening.PROSPERO REGISTRATION NUMBER: CRD42022318878.PMID:37489925 | DOI:10.1080/17512433.2023.2238602

Source: Expert Review of Clinical Pharmacology - July 25, 2023 Category: Drugs & Pharmacology Authors: Yi Zhang Zhuo Ma Yushu Wang Xin Feng Zhuoling An Source Type: research